Equities

Celcuity Inc

CELC:NAQ

Celcuity Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)10.16
  • Today's Change-0.25 / -2.40%
  • Shares traded33.95k
  • 1 Year change-1.55%
  • Beta0.6915
Data delayed at least 15 minutes, as of Jan 30 2023 21:00 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • CELC:NAQ price moved over +2.52% to 10.99
  • CELC:NAQ price rises above 50-day moving average to 10.77 at 11:42 GMT
  • CELC:NAQ trading volume exceeds daily average by +15.01%
  • CELC:NAQ price falls below 50-day moving average to 10.56 at 09:45 GMT

Key statistics

On Monday, Celcuity Inc (CELC:NAQ) closed at 10.16, -29.45% below its 52-week high of 14.40, set on Jan 03, 2023.
52-week range
Today
4.81May 17 202214.40Jan 03 2023
Markit short selling activity
Low
Med
High
Open10.29
High10.52
Low10.16
Bid9.65
Offer11.35
Previous close10.41
Average volume43.13k
Shares outstanding21.67m
Free float10.65m
P/E (TTM)--
Market cap225.56m USD
EPS (TTM)-2.38
USD
Data delayed at least 15 minutes, as of Jan 30 2023 21:00 GMT.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.